A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Clinical trial NCT05569746 · COMPLETED

Trial details

NCT number: NCT05569746
Sponsor: Inmunova S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diarrhea-Associated Hemolytic Uremic Syndrome Pediatric Kidney Disease Hemolytic-Uremic Syndrome

Start date: 2022-10-06
Primary completion: 2023-05-15
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.